ROY DOUMANI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROY DOUMANI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY DOUMANI. ROY DOUMANI is a Director in CTI MOLECULAR IMAGING INC ($CTMI) and a Director in Kite Pharma, Inc. ($KITE).
Address: 4 YAWL STREET VENICE 90292-7159 CA
Companies in which ROY DOUMANI is an Insider
CTI MOLECULAR IMAGING INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ROY DOUMANI: Director
Holdings: 0 shares
Latest Transaction: Jun 02 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROY DOUMANI: Director
Holdings: 1,807 shares
Current Value: $96,349
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROY DOUMANI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 6.89 | 30,000 | 206,700 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | U | 180.00 | 25,065 | 4,511,700 | 0 | 25.1 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | U | 180.00 | 150,620 | 27,111,600 | 1,807 | 152.4 K to 1.8 K (-98.81 %) |